2010年

Result

Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703).

Katai H, Sasako M, Fukuda H, Nakamura K, Hiki N, Saka M, Yamaue H, Yoshikawa T, Kojima K, JCOG Gastric Cancer Surgical Study Group

Gastric Cancer 13(4):238-44, 2010
Analysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery.

Kawai M, Yamaue H

Surg Today 40(11):1011-7, 2010
Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T cell response in patients with metastatic esophageal squamous cell carcinoma.

Iwahashi M, Katsuda M, Nakamori M, Nakamura M, Naka T, Ojima T, Iida T, Yamaue H

Cancer Sci 101(12):2510-7, 2010
Rectal obstruction by a giant pharmacobezoar composed of magnesium oxide: report of a case.

Shigekawa Y, Kobayashi Y, Higashiguchi T, Nasu T, Yamamoto M, Ochiai M, Tsuji T, Yamaue H

Surg Today 40(10):972-4, 2010
Combined use of contrast-enhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases.

Uchiyama K, Ueno M, Ozawa S, Kiriyama S, Shigekawa Y, Yamaue H

World J Surg 34(12):2953-9, 2010
SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.

Nishioka R, Itoh S, Gui T, Gai Z, Oikawa K, Kawai M, Tani M, Yamaue H, Muragaki Y

Exp Mol Pathol 89(2):149-57, 2010
A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study).

Yoshikawa T, Omura K, Kobayashi O, Nashimoto A, Takabayashi A, Yamada T, Yamaue H, Fujii M, Yamaguchi T, Nakajima T

Eur J Surg Oncol 36(6):546-51, 2010
MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography.

Shimamoto T, Tani M, Kawai M, Hirono S, Ina S, Miyazawa M, Shimizu A, Uchiyama K, Yokoyama S, Tsutsumi M, Yamaue H

Pancreas 39(6):879-83, 2010
Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.

Hayami S, Yoshimatsu M, Veerakumarasivam A, Unoki M, Iwai Y, Tsunoda T, Field HI, Kelly JD, Neal DE, Yamaue H, Ponder BA, Nakamura Y, Hamamoto R

Mol Cancer 9:59, 2010
Moderately differentiated colorectal adenocarcinoma as a lymph node metastatic phenotype: comparison with well differentiated counterparts.

Yokoyama S, Takifuji K, Hotta T, Matsuda K, Tominaga T, Oku Y, Nasu T, Tamura K, Ieda J, Yamaue H

BMC Surg 8;10:8, 2010
Hemangiopericytoma in the sacrococcygeal space: a case report.

Kitahata Y, Yokoyama S, Takifuji K, Hotta T, Matsuda K, Tominaga T, Oku Y, Watanabe T, Ieda J, Yamaue H

J Med Case Rep 4:8, 2010
A prospective randomized controlled trial of internal versus external drainage with pancreaticojejunostomy for pancreaticoduodenectomy.

Tani M, Kawai M, Hirono S, Ina S, Miyazawa M, Shimizu A, Yamaue H

Am J Surg 199(6):759-64, 2010
Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance.

Ina S, Hirono S, Noda T, Yamaue H

Pancreas 39(4):473-85, 2010
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer.

Miyazawa M, Ohsawa R, Tsunoda T, Hirono S, Kawai M, Tani M, Nakamura Y, Yamaue H

Cancer Sci 101(2):433-9, 2010
Clinicopathological characteristics of remnant gastric cancer after a distal gastrectomy.

Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M, Iida T, Tsuji T, Hayata K, Takifuji K, Yamaue H

J Gastrointest Surg 14(2):277-81, 2010
Middle pancreatectomy for pancreatic neoplasms.

Hirono S, Yamaue H

J Hepatobiliary Pancreat Sci 17(6):803-7, 2010
Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling.

Hirono S, Yamaue H, Hoshikawa Y, Ina S, Tani M, Kawai M, Ushijima M, Matsuura M, Saiki Y, Saiura A, Yamamoto J, Miki Y, Noda T

Cancer Sci 101(1):259-66, 2010
Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer.

Tominaga T, Iwahashi M, Takifuji K, Hotta T, Yokoyama S, Matsuda K, Higashiguchi T, Oku Y, Nasu T, Yamaue H

Int J Cancer 126(7):1691-701, 2010
The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma.

Kawai M, Tani M, Kobayashi Y, Tsuji T, Tabuse K, Horiuchi T, Oka M, Yamaguchi K, Sakata Y, Shimomura T, Yamaue H

Am J Surg 199(4):447-52, 2010
Clinicopathological features of anastomotic recurrence after an anterior resection for rectal cancer.

Matsuda K, Hotta T, Takifuji K, Yokoyama S, Oku Y, Yamaue H

Langenbecks Arch Surg 395(3):235-9, 2010

2010年

Result

2010年

Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703).

Analysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery.

Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T cell response in patients with metastatic esophageal squamous cell carcinoma.

Rectal obstruction by a giant pharmacobezoar composed of magnesium oxide: report of a case.

Combined use of contrast-enhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases.

SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.

A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study).

MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography.

Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.

Moderately differentiated colorectal adenocarcinoma as a lymph node metastatic phenotype: comparison with well differentiated counterparts.

Hemangiopericytoma in the sacrococcygeal space: a case report.

A prospective randomized controlled trial of internal versus external drainage with pancreaticojejunostomy for pancreaticoduodenectomy.

Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance.

Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer.

Clinicopathological characteristics of remnant gastric cancer after a distal gastrectomy.

Middle pancreatectomy for pancreatic neoplasms.

Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling.

Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer.

The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma.

Clinicopathological features of anastomotic recurrence after an anterior resection for rectal cancer.